Hualan Biological Bacterin Inc. (301207.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Address
No. 1, Westlands Road
Xinxiang, 453003
China
Phone
86 37 3355 9909
Sector
Healthcare
Industry
Biotechnology
Employees
748
First IPO Date
February 18, 2022
| Name | Title | Pay | Year Born |
| Wenjue An | GM & Director | 0 | 1989 |
| Ke Lu | Chief Financial Officer & Secretary | 0 | 1984 |
| Ruowen Pan | Executive Vice President & Director | 0 | 1968 |
Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on the entire vaccine lifecycle, from research and development to manufacturing and sales within China. The company's product line features a diverse range of immunizations, including various influenza virus vaccines (such as split, quadrivalent, and H1N1 strains), recombinant hepatitis B vaccines, and meningococcal polysaccharide vaccines (including ACYW135 and Group A & C types). They also develop genetically engineered vaccines for human use. Established in 2005, Hualan Biological Bacterin Inc. is headquartered in Xinxiang, China, and previously operated as a subsidiary of Hualan Biological Engineering Inc.